30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Myles David C.

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Myles David C.'s trades of Olema Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-14 2026-01-14
PrS Proposed sale
24,216
204.72
US$3,503,210 		24,216 204.72 US$3,503,210
2026-01-14 2026-01-14
S Sale
17,887 -42.2%
92.32
US$4,710,010 		17,887 -42.2% 92.32 US$4,710,010
2026-01-14 2026-01-14
S Sale
52,618 +29.5%
131.84
US$2,722,869 		52,618 +29.5% 131.84 US$2,722,869
2026-01-14 2026-01-13
S Sale
200 -0.0%
28.49
US$5,698 		200 -0.0% 28.49 US$5,698
2026-01-14 2026-01-13
S Sale
49,800 -8.4%
27.60
US$1,374,480 		49,800 -8.4% 27.60 US$1,374,480
2026-01-13 2026-01-13
PrS Proposed sale
50,000
27.60
US$1,380,113 		50,000 27.60 US$1,380,113
2026-01-14 2026-01-12
S Sale
10,000 -6.5%
28.34
US$283,400 		10,000 -6.5% 28.34 US$283,400
2026-01-12 2026-01-12
PrS Proposed sale
10,000
28.34
US$283,363 		10,000 28.34 US$283,363
2025-12-23 2025-12-19
S Sale
6,046 -1.1%
31.39
US$189,784 		6,046 -1.1% 31.39 US$189,784
2025-12-23 2025-12-19
S Sale
43,729 -7.3%
30.40
US$1,329,362 		43,729 -7.3% 30.40 US$1,329,362
2025-12-23 2025-12-19
PlS Planned sale
1,225 -0.2%
28.08
US$34,398 		1,225 -0.2% 28.08 US$34,398
2025-12-19 2025-12-19
PrS Proposed sale
51,000
30.46
US$1,553,447 		51,000 30.46 US$1,553,447
2024-12-11 2024-12-11
PrS Proposed sale
13,614
8.68
US$118,180 		13,614 8.68 US$118,180
2024-12-11 2024-12-11
S Sale
300 -0.1%
9.39
US$2,817 		300 -0.1% 9.39 US$2,817
2024-12-11 2024-12-11
S Sale
13,314 -2.2%
8.66
US$115,299 		13,314 -2.2% 8.66 US$115,299
2024-12-11 2024-12-10
S Sale
12,452 -2.0%
9.38
US$116,800 		12,452 -2.0% 9.38 US$116,800
2024-12-10 2024-12-10
PrS Proposed sale
12,452
9.38
US$116,748 		12,452 9.38 US$116,748
2023-11-22 2023-11-22
PrS Proposed sale
6,653
13.89
US$92,421 		6,653 13.89 US$92,421
2023-11-22 2023-11-22
S Sale
6,653 -1.1%
13.89
US$92,410 		6,653 -1.1% 13.89 US$92,410
2023-11-22 2023-11-21
S Sale
200 -0.0%
15.32
US$3,064 		200 -0.0% 15.32 US$3,064
2023-11-22 2023-11-21
S Sale
6,776 -1.2%
14.87
US$100,759 		6,776 -1.2% 14.87 US$100,759
2023-11-21 2023-11-21
PrS Proposed sale
6,976
14.88
US$103,806 		6,976 14.88 US$103,806
2023-11-13 2023-11-08
PlS Planned sale
200 -0.0%
17.61
US$3,522 		200 -0.0% 17.61 US$3,522
2023-11-08 2023-11-08
PrS Proposed sale
200
17.61
US$3,521 		200 17.61 US$3,521
2023-11-03 2023-11-03
PrS Proposed sale
541
17.51
US$9,474 		541 17.51 US$9,474
2023-11-03 2023-11-03
PlS Planned sale
541 -0.1%
17.51
US$9,473 		541 -0.1% 17.51 US$9,473
2023-11-03 2023-11-02
PlS Planned sale
3,332 -0.6%
15.36
US$51,180 		3,332 -0.6% 15.36 US$51,180
2023-11-02 2023-11-02
PrS Proposed sale
3,332
15.36
US$51,176 		3,332 15.36 US$51,176
2023-11-03 2023-11-01
PlS Planned sale
6,668 -1.2%
15.02
US$100,153 		6,668 -1.2% 15.02 US$100,153
2023-11-01 2023-11-01
PrS Proposed sale
6,668
15.02
US$100,126 		6,668 15.02 US$100,126
2023-09-21 2023-09-19
PlS Planned sale
20,000 -3.4%
12.67
US$253,400 		20,000 -3.4% 12.67 US$253,400
2023-09-19 2023-09-19
PrS Proposed sale
20,000
12.67
US$253,400 		20,000 12.67 US$253,400
2021-12-14 2021-12-10
PlS Planned sale
10,000 -1.7%
10.30
US$103,000 		10,000 -1.7% 10.30 US$103,000